Evaluation of Mean Platelet Volume and Systemic Inflammatory Response Index (SIRI) in Patients of Acute Coronary Syndrome

Launched by ·

Keywords

ClinConnect Summary

This clinical trial is looking at two blood markers called Mean Platelet Volume (MPV) and the Systemic Inflammatory Response Index (SIRI) to see how useful they are in diagnosing and predicting outcomes for people who have acute coronary syndrome—a condition that includes serious heart problems like heart attacks and unstable chest pain. The goal is to understand if these markers can help doctors better identify the severity of the condition and guide treatment decisions.

The study is open to adults of all genders, but there seems to be a wide and unusual age range listed, which might be a typo (typically, participants would be adults around 18 years and older). If you have recently experienced a heart event like a heart attack or unstable angina, you might be eligible to take part. Participants will likely have blood tests to measure MPV and SIRI, which involves simple blood draws. This study is not yet recruiting, so it’s important to check back later or talk to your doctor if you’re interested. Understanding these markers could help improve care for people with heart problems in the future.

Gender

ALL

Eligibility criteria